(Press-News.org) (WASHINGTON, April 28, 2011) – Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease (CGD) in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
CGD prevents neutrophils, a type of white blood cell of the immune system, from making hydrogen peroxide, an essential defense against life-threatening bacterial and fungal infections. Most cases of CGD are a result of a mutation on the X chromosome, a type of CGD that is called "X-linked" (X-CGD).
While antibiotics can treat infections caused by X-CGD, they do not cure the disease itself. Patients with X-CGD can be cured with a hematopoietic stem cell (HSC) transplant from healthy bone marrow; however, finding a compatible donor is difficult. Even with a suitable donor, patients are at risk of developing graft-versus-host disease (GVHD), a serious and often deadly post-transplant complication that occurs when newly transplanted donor cells recognize a recipient's own cells as foreign and attack the patient's body.
Another treatment option under development for X-CGD is gene therapy, a technique for correcting defective genes responsible for disease development that involves manipulation of genetic material within an individual's blood-forming stem cells using genetically engineered viruses. However, this gene therapy has so far proved to be inefficient at correcting X-CGD. In addition, these engineered viruses insert new genetic material at random locations in the blood-forming stem cell genome, putting patients at significantly higher risk for developing genetic mutations that may eventually lead to serious blood disorders, including blood cancer.
In order to develop a more effective and safer gene therapy for X-CGD, researchers from the National Institute of Allergy and Infectious Disease (NIAID) at the National Institutes of Health (NIH) and The Johns Hopkins University School of Medicine embarked on a study using a more precise method for performing gene therapy that did not use viruses for the gene correction. Researchers removed adult stem cells from the bone marrow of a patient with X-CGD and genetically reprogrammed them to become induced pluripotent stem cells (iPS cells). Like embryonic stem cells, these patient-specific iPS cells can be grown and manipulated indefinitely in culture while retaining their capacity to differentiate into any cell type of the body, including HSCs.
"HSCs that are derived from gene corrected iPS cells are tissue-compatible with the patient and may create a way for the patient's own cells to be used in a transplant to cure the disease, removing the risk of GVHD or the need to find a compatible donor," said Harry L. Malech, MD, senior study author, Chief of the Laboratory of Host Defenses and Head of the Genetic Immunotherapy Section of NIAID at the NIH. "However, turning iPS cells into a large number of HSCs that are efficently transplantable remains technically difficult; therefore, our study aimed at demonstrating that it is possible to differentiate gene corrected iPS cells into a large number of corrected neutrophils. These corrected neutrophils, grown in culture, are tissue-compatible with the patient and may be used to manage the life-threatening infections that are caused by the disease."
Typically, iPS cells from a patient with an inherited disorder do not express disease traits, despite the fact that the iPS cell genome contains the expected mutation. The researchers were able to prove, in culture, that iPS cells from a patient with X-CGD could be differentiated into mature neutrophils that failed to produce hydrogen peroxide, thus expressing the disease trait. This is the first study in which the disease phenotype has been reproduced in neutrophils differentiated from X-CGD patient-specific iPS cells.
After discovering that the disease could be reproduced in cell culture, the researchers then sought to correct the disease and produce healthy neutrophils in culture. They used synthetic proteins called zinc finger nucleases (ZFNs) to target a corrective gene at a specifically defined location in the genome of the X-CGD iPS cells. The iPS cells were then carefully screened to identify those containing a single copy of the corrective gene properly inserted only at the safe site. The researchers observed that some of the gene-corrected iPS cells could differentiate into neutrophils that produced normal levels of hydrogen peroxide, effectively "correcting" the disease.
"This is the first study that uses ZFNs in specific targeting gene transfer to correct X-CGD,"said Dr. Malech. "Demonstrating that this approach to gene therapy works with a single-gene disease such as X-CGD means that the results from our study offer not only a potential treatment for this disease, but more importantly, a technique by which other single-gene diseases can be corrected using specifically targeted gene therapy on iPS cells."
INFORMATION:
The American Society of Hematology is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online.
END
TORONTO, On – April 28, 2011 – Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
"Living in poor neighbourhoods has been linked with poor health outcomes, but this study shows that this is not always the case for new Canadians," says Dr. Marcelo Urquia, epidemiologist at the Centre for Research on Inner City Health at St. Michael's Hospital. "For new immigrants, while they have an advantage on avoiding premature ...
Researchers at the Center for Translational Social Neuroscience (CTSN) at Emory University are focusing on prairie voles as a new model to screen the effectiveness of drugs to treat autism.
They are starting with D-cycloserine, a drug Emory researchers have shown enhances behavioral therapy for phobias and also promotes pair bonding among prairie voles. Giving female voles D-cycloserine, which is thought to facilitate learning and memory, can encourage them to bond with a new male more quickly than usual.
The results are published online and will appear in a future ...
WASHINGTON — Structural Integrity of Offshore Wind Turbines: Oversight of Design, Fabrication, and Installation, a new report from the National Research Council's Transportation Research Board, examines standards and practices that could be used to design U.S. offshore wind installations.
In order to develop offshore wind energy in the United States, a clear set of requirements is needed, the report says. As the U.S. currently lacks standards, the committee that wrote the report recommends that the U.S. Department of the Interior's Bureau of Ocean Energy Management, ...
At the end of a long day on the job, the warehouse employee wants to deposit the last palettes quickly before heading home. With a little too much momentum he steers his forklift toward the shelf and collides with a shelf support. This is an every- day situation in large warehouses in which employees often have to maneuver goods through the narrow aisles, often under time pressure. Even harmless-seeming collisions are not really safe though, because over time they may in fact destabilize the shelf supports. In the worst case, the high-rack storage can come crashing down ...
Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.
The report, from the Comparison of AMD Treatments Trials (CATT), was published online in the New England Journal of Medicine on Sunday, May 1, 2011. CATT is funded by the National Eye Institute (NEI), a part of the National Institutes of Health.
"Over ...
Only when you are standing beside a wind turbine can you appreciate the immense size of the wind turbine and its rotor blades. The largest wind turbines operating in the world today have rotor blades over 60 meters long – roughly equivalent to three truck-and-trailer units end-to-end. Within the next ten years, manufacturers of high-output wind turbines for offshore wind farms plan to produce blades up to 90 meters long. The prototypes of these new blades have to be tested and certified before they can go into production, and that requires equally as large testing facilities.
The ...
A year after the BP explosion and oil spill, those trying to find someone to blame are misguided, says psychological scientist E. Scott Geller, Alumni Distinguished professor at Virginia Tech, and author of a new paper published in Current Directions in Psychological Science, a journal of the Association for Psychological Science. Geller has spent much of his 42-year career developing interventions to keep people safe, particularly helping companies develop a culture that promotes occupational safety.
There's almost never one person to blame for an injury; instead, companies ...
Nanoparticles will soon be used as tiny shuttles to deliver genes to cells and drugs to tumors in a more targeted way than was possible in the past.
But as the scientists prepare to use the nanoparticles in medicine, concerns have arisen about their potential toxicity.
Studies of both the applications of nanoparticles and their toxicity rely on the ability of scientists to quantify the interaction between the nanoparticles and cells, particularly the uptake (ingestion) of nanoparticles by cells.
In the standard laboratory tests of the biological activity of nanoparticles, ...
The fishing industry usually discards fish livers, but a team of researchers from the University of Almeria (Spain) has confirmed that they are a good source of polyunsaturated fatty acids, which are beneficial to health. Anchovies are one of the fish whose livers contain the highest levels of these substances.
Fish livers have hardly been used to date, with exceptions such as cod livers, which are used to produce the well-known medicinal oil. In general, fishermen tend to throw fish entrails away into the sea, and if they make it to processing plants they are one of ...
Dr. Michael Collins, Naval Research Laboratory scientist and bird watcher, has published an article titled "Putative audio recordings of the Ivory-billed Woodpecker (Campephilus principalis)" which appears in the March issue of the Journal of the Acoustical Society of America. The audio recordings were captured in two videos of birds with characteristics consistent with the Ivory-billed Woodpecker. This footage was obtained near the Pearl River in Louisiana, where there is a history of unconfirmed reports of this species. During five years of fieldwork, Collins had ten ...
